1. Home
  2. ANIK vs JYNT Comparison

ANIK vs JYNT Comparison

Compare ANIK & JYNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIK
  • JYNT
  • Stock Information
  • Founded
  • ANIK 1983
  • JYNT 2010
  • Country
  • ANIK United States
  • JYNT United States
  • Employees
  • ANIK N/A
  • JYNT N/A
  • Industry
  • ANIK Medical/Dental Instruments
  • JYNT Multi-Sector Companies
  • Sector
  • ANIK Health Care
  • JYNT Miscellaneous
  • Exchange
  • ANIK Nasdaq
  • JYNT Nasdaq
  • Market Cap
  • ANIK 133.1M
  • JYNT 149.5M
  • IPO Year
  • ANIK 1993
  • JYNT 2014
  • Fundamental
  • Price
  • ANIK $9.10
  • JYNT $8.69
  • Analyst Decision
  • ANIK Buy
  • JYNT Strong Buy
  • Analyst Count
  • ANIK 1
  • JYNT 3
  • Target Price
  • ANIK $15.00
  • JYNT $16.33
  • AVG Volume (30 Days)
  • ANIK 111.3K
  • JYNT 92.6K
  • Earning Date
  • ANIK 10-30-2025
  • JYNT 11-06-2025
  • Dividend Yield
  • ANIK N/A
  • JYNT N/A
  • EPS Growth
  • ANIK N/A
  • JYNT N/A
  • EPS
  • ANIK N/A
  • JYNT N/A
  • Revenue
  • ANIK $114,548,000.00
  • JYNT $53,449,713.00
  • Revenue This Year
  • ANIK N/A
  • JYNT $7.70
  • Revenue Next Year
  • ANIK $5.34
  • JYNT $10.24
  • P/E Ratio
  • ANIK N/A
  • JYNT N/A
  • Revenue Growth
  • ANIK 16.52
  • JYNT 277.36
  • 52 Week Low
  • ANIK $7.87
  • JYNT $8.69
  • 52 Week High
  • ANIK $25.65
  • JYNT $13.47
  • Technical
  • Relative Strength Index (RSI)
  • ANIK 49.54
  • JYNT 21.40
  • Support Level
  • ANIK $8.92
  • JYNT $9.06
  • Resistance Level
  • ANIK $9.54
  • JYNT $9.93
  • Average True Range (ATR)
  • ANIK 0.38
  • JYNT 0.32
  • MACD
  • ANIK 0.03
  • JYNT -0.10
  • Stochastic Oscillator
  • ANIK 47.79
  • JYNT 0.00

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has one operating business segment; The Franchise Operations segment which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the Company's franchise license, which represents symbolic intellectual property.

Share on Social Networks: